Cargando…

Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?

Detalles Bibliográficos
Autores principales:	Ferrara, Francesco, De Rosa, Francesco, Vitiello, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319216/ https://www.ncbi.nlm.nih.gov/pubmed/32838149 http://dx.doi.org/10.1007/s42399-020-00375-0

Ejemplares similares

The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care Unit
por: Ferrara, Francesco, et al.
Publicado: (2020)

COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy
por: Vitiello, Antonio, et al.
Publicado: (2020)

Antidiabetes Agents against Sars-Cov-2 Infection
por: Vitiello, Antonio, et al.
Publicado: (2020)

Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2021)

The Impact of COVID-19 Pandemic on Spine Surgeons Worldwide
por: Louie, Philip K., et al.
Publicado: (2020)

The COVID-19 Pandemic Sacrificed the Excellence of Stroke Care Worldwide
por: Vitturi, Bruno Kusznir
Publicado: (2021)

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
por: Bonavita, Simona, et al.
Publicado: (2020)

Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID-19 era
por: Toscano, Simona, et al.
Publicado: (2022)

Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
por: Sparaco, Maddalena, et al.
Publicado: (2022)

Recommendations to the government following the declaration of COVID-19 pandemic
Publicado: (2020)

Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
por: Kuzu Kumcu, Müge, et al.
Publicado: (2022)

Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study
por: Alirezaei, Mohammad, et al.
Publicado: (2021)

Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report
por: Giordano, Antonino, et al.
Publicado: (2021)

Dynamic interventions to control COVID-19 pandemic: a multivariate prediction modelling study comparing 16 worldwide countries
por: Chowdhury, Rajiv, et al.
Publicado: (2020)

COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
por: Sadeghmousavi, Shaghayegh, et al.
Publicado: (2020)

Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic
por: Gundavda, Manit K., et al.
Publicado: (2020)

Impact of COVID-19 lockdown on progressive multiple sclerosis patients
por: Vercellino, Marco, et al.
Publicado: (2022)

Effects of quarantine applied during the COVID-19 pandemic on mental health and quality of life in patients with multiple sclerosis and healthy controls
por: Koc, Emine Rabia, et al.
Publicado: (2022)

Review of Clinical and Operative Recommendations for Ophthalmology Practices During the COVID-19 Pandemic
por: Hoeferlin, Cory, et al.
Publicado: (2021)

Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis
por: Hada, Manila, et al.
Publicado: (2022)

Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
por: Habek, Mario
Publicado: (2021)

Impact of the COVID-19 pandemic on total, sex- and age-specific all-cause mortality in 20 countries worldwide during 2020: results from the C-MOR project
por: Demetriou, Christiana A, et al.
Publicado: (2022)

LGBTQ+ Inclusive Palliative Care in the Context of COVID-19: Pragmatic Recommendations for Clinicians
por: Rosa, William E., et al.
Publicado: (2020)

The future of neurology after the COVID-19 pandemic according to neurology residents
por: Ercoli, Tommaso, et al.
Publicado: (2022)

Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage
por: Shaygannejad, Vahid, et al.
Publicado: (2021)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

Endovascular Surgery during COVID-19 Virus Pandemic as a Valid Alternative to Open Surgery
por: Bozzani, Antonio, et al.
Publicado: (2021)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021)

The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness
por: De Lucia, Natascia, et al.
Publicado: (2020)

Changed pattern of hospital admission in stroke during COVID-19 pandemic period in Iran: a retrospective study
por: Tavanaei, Roozbeh, et al.
Publicado: (2021)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study
por: Dalla Costa, Gloria, et al.
Publicado: (2020)

COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis
por: Yazdani, Amid, et al.
Publicado: (2022)

Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide
por: Yetkin, Mehmet Fatih, et al.
Publicado: (2021)

Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge
por: D’Apolito, Maria, et al.
Publicado: (2023)

Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study
por: Affinito, Giuseppina, et al.
Publicado: (2023)

Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
por: Devogelaere, Jens, et al.
Publicado: (2020)

Acute cerebellitis requiring posterior fossa decompression after COVID-19 vaccination in an ocrelizumab-treated patient with multiple sclerosis
por: Brecl Jakob, Gregor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f3t87bbbjreq0d40mqohej8514